Less Ads, More Data, More Tools Register for FREE

Pin to quick picksABD.L Regulatory News (ABD)

  • There is currently no data for ABD

Research from QuotedData

7 Jun 2022 15:31

RNS Number : 0437O
abrdn New Dawn Invest Trust plc
07 June 2022
 

abrdn New Dawn - Research from QuotedData

 

7th June 2022

 

Over the trough?

 

It has been another tough six months for abrdn New Dawn (ABD) as the Asia Pacific region has had to face new challenges from the Russo-Ukrainian conflict to China's deadliest COVID-19 wave yet (the economic impacts of which have been made worse by Xi Jinping's zero-COVID policy). This has only exacerbated headwinds already in place such as rising inflation. Manager James Thom believes the worst is behind us, but uncertainty and volatility remain. The trust itself has underperformed in the short-term but still boasts strong long-term numbers and, if a new dawn is indeed rising over the region, with India finally enjoying its reformation and the vaccine rollout (mostly) underway, now could be an attractive entry point. The trust is also trading on an 12.4% discount.

 

Full research:

https://quoteddata.com/research/abrdn-new-dawn-over-the-trough-qd/

 

This research is also available free on our website www.quoteddata.com where you will also find news, performance data and factsheets on every London listed Investment Company. QuotedData writes and distributes research on a number of quoted companies, facilitates meetings between those companies and existing and potential investors and assists in raising additional capital where required.

 

NB: Marten & Co was paid to produce this note on abrdn New Dawn Investment Trust Plc and it is for information purposes only. It is not intended to encourage the reader to deal in the security or securities mentioned in this report. Please read the important information at the back of this note. QuotedData is a trading name of Marten & Co Limited which is authorised and regulated by the FCA. Marten & Co is not permitted to provide investment advice to individual investors.

QUOTEDDATA123a Kings Road | London SW3 4PLTel: +44 (0) 20 3691 9430

www.quoteddata.com | research@quoteddata.com | www.martenandco.com

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRAUBUSRUKUNRAR
Date   Source Headline
11th May 202212:42 pmRNSNet Asset Value(s)
10th May 20221:03 pmRNSNet Asset Value(s)
9th May 20225:06 pmRNSTransaction in Own Shares
9th May 20222:33 pmRNSHolding(s) in Company
9th May 20222:08 pmRNSGearing disclosure
9th May 20221:20 pmRNSNet Asset Value(s)
6th May 20225:17 pmRNSMonth End Net Asset Value(s)
6th May 202212:07 pmRNSNet Asset Value(s)
5th May 20225:16 pmRNSTransaction in Own Shares
5th May 202212:28 pmRNSNet Asset Value(s)
4th May 20225:06 pmRNSTransaction in Own Shares
4th May 20223:21 pmRNSQuarterly disclosure
4th May 202212:46 pmRNSNet Asset Value(s)
3rd May 20225:50 pmRNSGearing Disclosures
3rd May 20225:07 pmRNSTransaction in Own Shares
3rd May 202210:07 amRNSTotal Voting Rights
29th Apr 20225:06 pmRNSTransaction in Own Shares
29th Apr 202212:32 pmRNSHolding(s) in Company
29th Apr 202211:36 amRNSNet Asset Value(s)
28th Apr 20225:02 pmRNSTransaction in Own Shares
28th Apr 202212:13 pmRNSNet Asset Value(s)
27th Apr 202212:51 pmRNSNet Asset Value(s)
26th Apr 20225:08 pmRNSTransaction in Own Shares
26th Apr 202212:36 pmRNSNet Asset Value(s)
25th Apr 20222:50 pmRNSGearing Disclosure
25th Apr 20221:04 pmRNSNet Asset Value(s)
22nd Apr 20225:04 pmRNSTransaction in Own Shares
22nd Apr 20221:21 pmRNSNet Asset Value(s)
21st Apr 202212:38 pmRNSNet Asset Value(s)
20th Apr 202212:28 pmRNSNet Asset Value(s)
19th Apr 20226:00 pmRNSGearing Disclosure
19th Apr 20221:07 pmRNSNet Asset Value(s)
19th Apr 202210:18 amRNSPortfolio Disclosures
14th Apr 202212:38 pmRNSNet Asset Value(s)
13th Apr 202212:05 pmRNSNet Asset Value(s)
12th Apr 202212:35 pmRNSHolding(s) in Company
12th Apr 202212:25 pmRNSNet Asset Value(s)
11th Apr 20222:13 pmRNSGearing disclosure
11th Apr 202212:19 pmRNSNet Asset Value(s)
8th Apr 20225:11 pmRNSTransaction in Own Shares
8th Apr 202212:02 pmRNSNet Asset Value(s)
7th Apr 202212:37 pmRNSNet Asset Value(s)
7th Apr 202210:18 amRNSMonth End Net Asset Value(s)
6th Apr 20225:08 pmRNSTransaction in Own Shares
6th Apr 202212:47 pmRNSNet Asset Value(s)
5th Apr 20225:06 pmRNSTransaction in Own Shares
5th Apr 20224:28 pmRNSHolding(s) in Company
5th Apr 20221:00 pmRNSNet Asset Value(s)
4th Apr 20225:16 pmRNSTransaction in Own Shares
4th Apr 20221:36 pmRNSGearing disclosure

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.